SCHEMBL1247342

SCHEMBL1247342

Cc1onc(-c2ccc(-c3ccccc3CC(=O)O)cc2)c1NC(=O)OCCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.46
SCN5A Q14524 3/20 0.46
NPSR1 Q6W5P4 1/20 0.45
ENPP2 Q13822 1/20 0.44
NTRK1 P04629 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ROCK2 O75116 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MGLL Q99685 1/20 0.40
MAPT P10636 2/20 0.39
ATM Q13315 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1247134 0.91 SCN9A (0.56) SCN9ASCN5ANTRK1ALDH1A1MAPT
SCHEMBL1247418 0.88 LPAR1 (0.48) SCN9ASCN5ANPSR1ENPP2NTRK1
SCHEMBL4036879 0.87 NPSR1 (0.56) SCN9ASCN5ANPSR1NTRK1L3MBTL1
SCHEMBL1247169 0.85 MGLL (0.52) SCN9ASCN5ANPSR1ENPP2NTRK1
SCHEMBL3709529 0.85 LPAR1 (0.54) ENPP2ALDH1A1ROCK2SMN1; SMN2MGLL
SCHEMBL1246454 0.83 NPSR1 (0.48) SCN9ASCN5ANPSR1NTRK1L3MBTL1
SCHEMBL1246325 0.83 SCN9A (0.46) SCN9ASCN5ANPSR1ENPP2NTRK1
SCHEMBL1245362 0.82 SCN9A (0.57) SCN9ASCN5ANPSR1NTRK1SMN1; SMN2
SCHEMBL1245296 0.82 SCN9A (0.55) SCN9ASCN5ANPSR1NTRK1ALDH1A1
SCHEMBL1245272 0.81 SCN9A (0.45) SCN9ASCN5ANPSR1ENPP2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462128-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
WO-2011017350-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed